We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+6.25%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$17.4B
AUM Growth
+$904M
Cap. Flow
+$84.9M
Cap. Flow %
0.49%
Top 10 Hldgs %
29.78%
Holding
722
New
36
Increased
329
Reduced
218
Closed
40

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$66.4M
2
REGN icon
Regeneron Pharmaceuticals
REGN
+$57.7M
3
AMZN icon
Amazon
AMZN
+$56.5M
4
AMD icon
Advanced Micro Devices
AMD
+$37.5M
5
CRM icon
Salesforce
CRM
+$35.5M

Top Sells

Rank Stock Value
1
LRCX icon
Lam Research
LRCX
+$122M
2
TMO icon
Thermo Fisher Scientific
TMO
+$60.8M
3
AMAT icon
Applied Materials
AMAT
+$43.7M
4
NU icon
Nu Holdings
NU
+$35.9M
5
INCY icon
Incyte
INCY
+$32.5M

Sector Composition

Rank Sector Weight
1 Technology 31.8%
2 Healthcare 28.54%
3 Financials 9.44%
4 Consumer Discretionary 7.84%
5 Industrials 7.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PLTR icon
376
Palantir
PLTR
$295B
$4.42M 0.03%
118,746
+21,078
+22% +$647K
EIX icon
377
Edison International
EIX
$30.3B
$4.37M 0.03%
50,200
-1,514
-3% -$123K
IMCR icon
378
Immunocore
IMCR
$1.7B
$4.36M 0.03%
140,006
-173,417
-55% -$6.31M
CCI icon
379
Crown Castle
CCI
$34.6B
$4.32M 0.02%
36,400
+2,425
+7% +$267K
MPC icon
380
Marathon Petroleum
MPC
$90.1B
$4.29M 0.02%
26,342
+431
+2% +$72.8K
SYY icon
381
Sysco
SYY
$40.8B
$4.27M 0.02%
54,743
+2,650
+5% +$199K
PAYX icon
382
Paychex
PAYX
$43.4B
$4.27M 0.02%
31,834
+1,938
+6% +$246K
PAYC icon
383
Paycom
PAYC
$7.88B
$4.19M 0.02%
25,157
+20,679
+462% +$3.31M
CAG icon
384
Conagra Brands
CAG
$7.42B
$4.19M 0.02%
128,852
+255
+0.2% +$7.82K
EXPD icon
385
Expeditors International
EXPD
$22.3B
$4.17M 0.02%
31,762
+401
+1% +$49.1K
CBOE icon
386
Cboe Global Markets
CBOE
$32.2B
$4.15M 0.02%
20,282
+4,563
+29% +$896K
PCAR icon
387
PACCAR
PCAR
$70.5B
$4.11M 0.02%
41,692
+582
+1% +$56.9K
AOS icon
388
A.O. Smith
AOS
$8.55B
$4.1M 0.02%
+45,674
New +$3.78M
KR icon
389
Kroger
KR
$36.7B
$4.08M 0.02%
71,199
– –
AFL icon
390
Aflac
AFL
$65.5B
$4.08M 0.02%
36,489
+1,074
+3% +$109K
STT icon
391
State Street
STT
$48.4B
$4.05M 0.02%
45,749
-2,937
-6% -$242K
DAWN
392
DELISTED
Day One Biopharmaceuticals
DAWN
$4.04M 0.02%
290,014
– –
PSX icon
393
Phillips 66
PSX
$82.9B
$3.95M 0.02%
30,062
+3,246
+12% +$438K
VRSK icon
394
Verisk Analytics
VRSK
$27.9B
$3.84M 0.02%
14,345
+831
+6% +$225K
NDAQ icon
395
Nasdaq
NDAQ
$53.4B
$3.83M 0.02%
52,483
-1,052
-2% -$71.8K
BLDR icon
396
Builders FirstSource
BLDR
$7.29B
$3.82M 0.02%
19,705
+11,433
+138% +$1.9M
WIT icon
397
Wipro
WIT
$19.5B
$3.76M 0.02%
1,160,000
-580,000
-33% -$1.82M
ORLY icon
398
O'Reilly Automotive
ORLY
$75.1B
$3.75M 0.02%
48,795
+300
+0.6% +$22K
CMI icon
399
Cummins
CMI
$83.6B
$3.73M 0.02%
11,511
+1,045
+10% +$310K
AGCO icon
400
AGCO
AGCO
$8.41B
$3.67M 0.02%
37,545
-2,407
-6% -$224K
14 15
16
17 18

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q3 2024 Portfolio in Review

As of Q3 2024, Candriam SCA held 722 positions worth $17.4B, up 5.5% from $16.5B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Candriam SCA's Q3 2024 filing shows 36 new, 329 increased, 218 reduced and 40 closed positions. Its largest new stake was Avidity Biosciences: 323,396 shares worth $14.9M. The largest sale was Lam Research, an estimated $122M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 33% a quarter earlier, followed by Healthcare and Financials.

  • Candriam SCA's largest Q3 2024 buy was Avidity Biosciences: 323,396 shares worth $14.9M.
  • Candriam SCA added most to Amgen in Q3 2024, an estimated $66.4M increase.
  • Candriam SCA's biggest Q3 2024 reduction was Thermo Fisher Scientific, cutting an estimated $60.8M.
  • Candriam SCA fully exited Lam Research in Q3 2024, selling an estimated $122M.
  • Candriam SCA's ten largest holdings make up 30% of its $17.4B portfolio in Q3 2024.
  • Candriam SCA opened 36 new positions and closed 40 in Q3 2024.
  • Candriam SCA's portfolio value rose 5.5% quarter-over-quarter to $17.4B.

Based on Candriam SCA's 13F filing for Q3 2024, filed 13 Nov 2024.